Sex: U
Vaccine: IPV, MNQ, TD
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: temperature excursion due to a malfunction of the thermometer. The lowest temperature it reached was 29.8F for a total duration out of range of 1 day, 23 hours and zero minutes with no reported adverse event; product TENIVAC, MENACTRA has been administered since the excursion with no reported adverse event; Initial information was received on 17-Mar-2023 regarding an unsolicited valid non-serious case received from a physician.  This case involves an unknown age and unknown gender patient who experienced temperature excursion due to a malfunction of the thermometer. the lowest temperature it reached was 29.8f for a total duration out of range of 1 day, 23 hours and zero minutes with no reported adverse event and product tenivac, menactra has been administered since the excursion with no reported adverse event while receiving vaccines ipv (VERO) [Ipol], meningococcal a-c-y-w135 (d conj) vaccine [Menactra] and diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT [Tenivac].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT Suspension for injection (with an unknown strength, dose, frequency, route, batch number, expiry date) in unknown administration site for Immunization.  On an unknown date, the patient received a dose of suspect meningococcal a-c-y-w135 (d conj) vaccine Solution for injection (with an unknown strength, dose, frequency, route, batch number, expiry date) in unknown administration site for Immunization.  On an unknown date, the patient received a dose of suspect ipv (VERO) Suspension for injection (with an unknown strength, dose, frequency, route, batch number, expiry date) in unknown administration site for Immunization.  On an unknown date the patient developed a non-serious event of temperature excursion due to a malfunction of the thermometer. the lowest temperature it reached was 29.8f for a total duration out of range of 1 day, 23 hours and zero minutes with no reported adverse event (product storage error) (unknown latency) following the administration of diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT, (unknown latency) following the administration of meningococcal a-c-y-w135 (d conj) vaccine and (unknown latency) following the administration of ipv (VERO).  On an unknown date the patient developed a non-serious event of product tenivac, menactra has been administered since the excursion with no reported adverse event (poor quality product administered) 1 day following the administration of diphtheria-2/tetanus-5 adsorbed toxoids NO PRESERVATIVE ADULT, 1 day following the administration of meningococcal a-c-y-w135 (d conj) vaccine and 1 day following the administration of ipv (VERO).  It was reported "PA returning call from a report that was called in on 14OCT2022. PA updated the temperature excursion due to a malfunction of the thermometer. The lowest temperature it reached was 29.8F for a total duration out of range of 1 day, 23 hours and zero minutes. The unopened products were: TENIVAC, MENACTRA, IPOL (open and has been discarded). Extended stability data does not cover unopened products. PA said since the temperature provided was incorrect the product TENIVAC, MENACTRA has been administered since the excursion".  Action taken: was not applicable.  At time of reporting, the outcome was Unknown for the event temperature excursion due to a malfunction of the thermometer. the lowest temperature it reached was 29.8f for a total duration out of range of 1 day, 23 hours and zero minutes with no reported adverse event and was Unknown for the event product tenivac, menactra has been administered since the excursion with no reported adverse event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.